Table 1.
Symbol | Description | Fold change (compared to control) | ||||
---|---|---|---|---|---|---|
0HR | 8HR | 24HR | 48HR | 72HR | ||
Bcl2a1a | B‐cell leukemia/lymphoma 2‐related protein A1a | −2.0431 | ||||
Bcl2 l2 | Bcl2‐like 2 | 2.4361 | ||||
Bid | BH3 interacting domain death agonist | −2.2903 | ||||
Cd40lg | CD40 ligand | −3.4419 | −2.1382 | −2.3453 | −4.1212 | −3.0682 |
Cidea | Cell death‐inducing DNA fragmentation factor, alpha subunit‐like effector A | 2.7106 | ||||
Fasl | Fas ligand (TNF superfamily, member 6) | 3.0694 | ||||
Naip1 | NLR family, apoptosis inhibitory protein 1 | −2.0706 | ||||
Nme5 | Nonmetastatic cells 5, protein expressed in nucleoside‐diphosphate kinase | −5.2929 | ||||
Tnf | Tumor necrosis factor | −2.5708 | −2.9582 | |||
Tnfrsf11b | Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) | 2.3673 | 2.9286 | 6.7222* | ||
Trp73 | Transformation‐related protein 73 | −2.1761 | 3.5429 |
*P ≤ 0.05 from sedentary control.